There is compelling evidence that oral daily dosing of memantine is effective for reduction of functional loss associated with experimental glaucoma in monkeys*. The current study evaluated the effects of a single oral dose of memantine (20 mg/kg) on retinal histology produced by an acute retinal ischemic insult in rabbits
Background and purposeStroke treatment is constrained by limited treatment windows and the clinical ...
Excitotoxicity is a major contributor to cell death during the acute phase of ischemic stroke but ag...
Glaucoma is characterized by an accelerated loss of retinal ganglion cells, as a result of damage to...
Purpose. To develop an improved (1This is to clearly acknowledge that we have tried to improve an ex...
Purpose: This study applies treatment methods to rat retinas subjected to acute ischemia reperfusion...
AbstractBackground: This study was conducted to investigate the effect of memantine, a noncompetitiv...
AIM: To prepare and evaluate the in vitro release of memantine-loaded poly(anhydride) (Gantrez®) ...
Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC) ...
Excitotoxicity is a major contributor to cell death during the acute phase of ischemic stroke but ag...
Memantine is an uncompetitive antagonist with moderate affinity for NMDA receptors, and it demonstra...
Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC) ...
Purpose: To evaluate the effects of memantine on improving visual function in patients with acute no...
PurposeTo evaluate the effectiveness and safety of oral memantine as a potential neuroprotective age...
Purpose: Memantine (MEM) acts on the glutamatergic system by blocking N-methyl-d-aspartate (NMDA) gl...
Spinocerebellar ataxias are a family of fatal inherited diseases affecting the brain. Although speci...
Background and purposeStroke treatment is constrained by limited treatment windows and the clinical ...
Excitotoxicity is a major contributor to cell death during the acute phase of ischemic stroke but ag...
Glaucoma is characterized by an accelerated loss of retinal ganglion cells, as a result of damage to...
Purpose. To develop an improved (1This is to clearly acknowledge that we have tried to improve an ex...
Purpose: This study applies treatment methods to rat retinas subjected to acute ischemia reperfusion...
AbstractBackground: This study was conducted to investigate the effect of memantine, a noncompetitiv...
AIM: To prepare and evaluate the in vitro release of memantine-loaded poly(anhydride) (Gantrez®) ...
Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC) ...
Excitotoxicity is a major contributor to cell death during the acute phase of ischemic stroke but ag...
Memantine is an uncompetitive antagonist with moderate affinity for NMDA receptors, and it demonstra...
Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC) ...
Purpose: To evaluate the effects of memantine on improving visual function in patients with acute no...
PurposeTo evaluate the effectiveness and safety of oral memantine as a potential neuroprotective age...
Purpose: Memantine (MEM) acts on the glutamatergic system by blocking N-methyl-d-aspartate (NMDA) gl...
Spinocerebellar ataxias are a family of fatal inherited diseases affecting the brain. Although speci...
Background and purposeStroke treatment is constrained by limited treatment windows and the clinical ...
Excitotoxicity is a major contributor to cell death during the acute phase of ischemic stroke but ag...
Glaucoma is characterized by an accelerated loss of retinal ganglion cells, as a result of damage to...